Pharmaceutical Industry Information Portal


All posts by tag


China Meheco signs deal with Pfizer to supply Covid-19 pill

China Meheco Group Co Ltd signed an agreement with Pfizer Inc to supply the latter's COVID-19 treatment Paxlovid in the Chinese mainland in 2022,...

China approves Pfizer’s Covid-19 pill Paxlovid

China's medical products regulator said on Saturday it has given conditional approval for Pfizer's COVID-19 drug Paxlovid, making it the first oral pill specifically...

Pfizer Covid Pill Europe’s First Approved Oral Treatment Against Covid

Pfizer announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending the...

European Medicines Agency receives application for conditional marketing authorisation for Paxlovid

EMA has started evaluating an application for a conditional marketing authorisation for the oral antiviral medicine Paxlovid (PF-07321332 and ritonavir). The applicant is Pfizer...

Pfizer Receives U.S. FDA Emergency Use Authorization for Novel COVID-19 Oral Antiviral Treatment

Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has authorized the emergency use of PAXLOVID™ (nirmatrelvir tablets and ritonavir tablets)...

Expert Articles